» Articles » PMID: 34315005

Mycobacterial Diseases in Patients with Inborn Errors of Immunity

Overview
Publisher Elsevier
Date 2021 Jul 27
PMID 34315005
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical disease caused by the agent of tuberculosis, Mycobacterium tuberculosis, and by less virulent mycobacteria, such as bacillus Calmette-Guérin (BCG) vaccines and environmental mycobacteria, can result from inborn errors of immunity (IEIs). IEIs underlie more than 450 conditions, each associated with an impairment of the development and/or function of hematopoietic and/or non-hematopoietic cells involved in host defense. Only a minority of IEIs confer predisposition to mycobacterial disease. The IEIs underlying susceptibility to bona fide tuberculosis are less well delineated than those responsible for susceptibility to less virulent mycobacteria. However, all these IEIs share a defining feature: the impairment of immunity mediated by interferon gamma (IFN-γ). More profound IFN-γ deficiency is associated with a greater vulnerability to weakly virulent mycobacteria, whereas more selective IFN-γ deficiency is associated with a more selective predisposition to mycobacterial disease. We review here recent progress in the study of IEIs underlying mycobacterial diseases.

Citing Articles

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents.

Picchianti-Diamanti A, Aiello A, De Lorenzo C, Migliori G, Goletti D Front Immunol. 2025; 16:1494283.

PMID: 39963138 PMC: 11830708. DOI: 10.3389/fimmu.2025.1494283.


Clinical and immunological features of specific antibody deficiency in a pediatric hospital in Colombia.

Castano-Jaramillo L, Munevar A, Marin A, Villamil M, Restrepo S, Velez N Biomedica. 2025; 44(Sp. 2):72-79.

PMID: 39836839 PMC: 11809488. DOI: 10.7705/biomedica.7562.


Metformin improves infection by strengthening macrophage antimicrobial functions.

Mediaas S, Haug M, Louet C, Wahl S, Gidon A, Flo T Front Immunol. 2024; 15:1463224.

PMID: 39737195 PMC: 11682992. DOI: 10.3389/fimmu.2024.1463224.


First Brazilian Case Report of Unrelated Patients with Identical ISG15 Mutation.

da Silva Napoleao S, Salgado R, Ferreira J, de Barros Dorna M, de Moura T, Franca T J Clin Immunol. 2024; 45(1):21.

PMID: 39365299 DOI: 10.1007/s10875-024-01811-9.


Tuberculosis in otherwise healthy adults with inherited TNF deficiency.

Arias A, Neehus A, Ogishi M, Meynier V, Krebs A, Lazarov T Nature. 2024; 633(8029):417-425.

PMID: 39198650 PMC: 11390478. DOI: 10.1038/s41586-024-07866-3.


References
1.
Holland S . Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013; 27(1):89-99, viii. PMC: 3558921. DOI: 10.1016/j.hoc.2012.11.002. View

2.
Boisson-Dupuis S, El Baghdadi J, Parvaneh N, Bousfiha A, Bustamante J, Feinberg J . IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One. 2011; 6(4):e18524. PMC: 3076373. DOI: 10.1371/journal.pone.0018524. View

3.
Bogunovic D, Byun M, Durfee L, Abhyankar A, Sanal O, Mansouri D . Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science. 2012; 337(6102):1684-8. PMC: 3507439. DOI: 10.1126/science.1224026. View

4.
Tabarsi P, Marjani M, Mansouri N, Farnia P, Boisson-Dupuis S, Bustamante J . Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency. J Clin Immunol. 2011; 31(4):537-9. DOI: 10.1007/s10875-011-9523-9. View

5.
Mauch R, Mansinho A, Rocha P, Zaccariotto T, Levy C, Nolasco da Silva M . Nontuberculous mycobacterial infections in a Brazilian pediatric population: a seven-year survey. Pathog Glob Health. 2020; 114(2):104-108. PMC: 7170317. DOI: 10.1080/20477724.2020.1725330. View